Hepion Pharmaceuticals to Present at NASH-TAG 2024
EDISON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on...
Source: globenewswire.com
Hepquant Duo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hepquant Duo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hepquant Duo Today - Breaking & Trending Today
Hepion Pharmaceuticals to Present at NASH-TAG 2024
EDISON, N.J., Jan. 03, 2024 -- Hepion Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company focused on Artificial Intelligence -driven therapeutic drug development for the treatment of...
Source: marketscreener.com
Hepion Pharmaceuticals Announces Major Reductions in Liver
- Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease...
Source: globenewswire.com
Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease…
Source: biztoc.com